[EN] MODULATORS OF ARALAR FOR TREATING NEUROLOGICAL DISORDERS<br/>[FR] MODULATEURS D'ARALAR POUR LE TRAITEMENT DE TROUBLES NEUROLOGIQUES
申请人:UNIV LAUSANNE
公开号:WO2021176098A1
公开(公告)日:2021-09-10
The present invention relates to compounds or pharmaceutical compositions for treating neurological disorders. In particular, the invention relates to a modulator of gamma- Aminobutyric acid (GABA) signaling for use in treating a neurological disorder in a subject with Cyfipl haploinsufficiency. Furthermore, the present invention relates to a modulator of Aralar for use in treating a neurological disorder. The invention further relates to non-medical uses of the compounds or compositions of the invention. Furthermore, the invention relates to a method for identifying a modulator of Aralar and/or a neuroactive drug.
A Convenient Synthesis of Esters of β-Phenylglutamic Acid Under Aqueous Conditions
作者:D. Tasheva、N. Petkova、V. Dryanska
DOI:10.1081/scc-120025174
日期:2003.11
Several esters of beta-phenylglutamic acid (3, 4) are prepared by Michael reaction of glycine ester Schiff bases 1 and 2 under aqueous conditions.
Synthesis and structure of (het)arylglutamic acids and pyroglutamic acid hydrazides
作者:O. S. Vasil´eva、B. M. Berestovitskaya、I. N. Tyurenkov、E. S. Ostroglyadov、V. N. Perfilova、N. V. Gorodnicheva、A. I. Yaremchuk
DOI:10.1007/s11172-017-1913-6
日期:2017.8
Hydrochlorides of (2R*,3R*)-3-(het)arylglutamic acid diesters were synthesized by esterification of the corresponding glutamic acids (Glu). Diesters reacted with hydrazine hydrate to give (4R*,5R*)-2-pyrrolidone-5-carboxylic acid hydrazides. Hydrochlorides of glutamic acids diesters were found to exhibit cardioprotective properties against acute and chronic stress myocardial damage.